Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Townson Sharon. Officer active across 1 company, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 7 reports have been recorded. Split: 0 buy · 3 sells. Total volume traded: €122k. Activity tracked since 6 July 2026. The latest transaction was disclosed on 6 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Townson Sharon is a declarant linked to Monte Rosa Therapeutics, Inc., where the listed role is Chief Scientific Officer. She has 7 filings in total, and across the 7 sampled filings, the recorded transactions run from 2025-01-06 to 2026-07-07, with EUR 0 in buys and EUR 122270 in sells; the modal transaction nature is Disposal.